151 related articles for article (PubMed ID: 33368817)
1. Comparing neuropathy in multiple myeloma and AL amyloidosis.
Ballegaard M; Nelson LM; Gimsing P
J Peripher Nerv Syst; 2021 Mar; 26(1):75-82. PubMed ID: 33368817
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis.
Chompoopong P; Almarwani B; Katirji B
J Neurol Sci; 2021 Mar; 422():117336. PubMed ID: 33578240
[TBL] [Abstract][Full Text] [Related]
3. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study.
Matsuda M; Gono T; Morita H; Katoh N; Kodaira M; Ikeda S
Eur J Neurol; 2011 Apr; 18(4):604-10. PubMed ID: 20860753
[TBL] [Abstract][Full Text] [Related]
4. Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Manwani R; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Yong K; Rabin N; Popat R; Kyriakou C; Worthington S; Sharpley F; Smith M; Shah R; Cheesman S; Hawkins PN; Wechalekar AD
Br J Haematol; 2019 Dec; 187(5):638-641. PubMed ID: 31388995
[TBL] [Abstract][Full Text] [Related]
5. On-nerve needle nerve conduction study in the sural nerve: A new technique for evaluation of peripheral neuropathy.
Oh SJ; Hemmi S; Hatanaka Y
Clin Neurophysiol; 2015 Sep; 126(9):1811-6. PubMed ID: 25727898
[TBL] [Abstract][Full Text] [Related]
6. An observational study assessing peripheral neuropathy related to multiple myeloma.
Leone C; Federico V; La Cesa S; Russo E; Di Stefano G; Finsinger P; Labriola R; Cruccu G; Petrucci MT; Truini A
Neurol Sci; 2016 Jul; 37(7):1141-3. PubMed ID: 26960791
[TBL] [Abstract][Full Text] [Related]
7. Superficial peroneal sensory and sural nerve conduction studies in peripheral neuropathy.
Lo YL; Xu LQ; Leoh TH; Dan YF; Tan YE; Nurjannah S; Ratnagopal P
J Clin Neurosci; 2006 Jun; 13(5):547-9. PubMed ID: 16678425
[TBL] [Abstract][Full Text] [Related]
8. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
9. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Blau T; Reinhardt HC; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
J Neurol Sci; 2022 Sep; 440():120341. PubMed ID: 35872471
[TBL] [Abstract][Full Text] [Related]
11. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy, M components, and amyloid.
Benson MD; Cohen AS; Brandt KD; Cathcart ES
Lancet; 1975 Jan; 1(7897):10-2. PubMed ID: 46335
[TBL] [Abstract][Full Text] [Related]
13. Leprosy neuropathy evaluated by NCS is independent of the patient's infectious state.
Jardim MR; Vital R; Hacker MA; Nascimento M; Balassiano SL; Sarno EN; Illarramendi X
Clin Neurol Neurosurg; 2015 Apr; 131():5-10. PubMed ID: 25655301
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of peripheral neuropathy in myeloma.
Kelly JJ; Kyle RA; Miles JM; O'Brien PC; Dyck PJ
Neurology; 1981 Jan; 31(1):24-31. PubMed ID: 6256682
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological determinants of the clinical severity of axonal peripheral neuropathy.
Zis P; Hadjivassiliou M; Rao DG; Sarrigiannis PG
Muscle Nerve; 2019 Apr; 59(4):491-493. PubMed ID: 30680742
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
Pogorzelski R; Baniukiewicz E; Drozdowski W
Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Glycated Hemoglobin and Body Mass Index for Pretreatment Neuropathy in Patients With Multiple Myeloma.
Lakshman A; Modi M; Prakash G; Malhotra P; Khadwal A; Suri V; Dutta P; Jain S; Kumari S; Varma N; Varma S
Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):89-95. PubMed ID: 26689624
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
[TBL] [Abstract][Full Text] [Related]
19. Total neuropathy score: validation and reliability study.
Cornblath DR; Chaudhry V; Carter K; Lee D; Seysedadr M; Miernicki M; Joh T
Neurology; 1999 Nov; 53(8):1660-4. PubMed ID: 10563609
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Nervous System Involvement.
Thaisetthawatkul P; Dyck PJB
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1091-1098. PubMed ID: 33099426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
